Mundaring, Australia

Mark Fear




Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Perth, AU (2011)
  • Mundaring, AU (2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark Fear: Pioneering Innovations in Wound Treatment and Neuroprotection

Introduction

Mark Fear, an innovative inventor based in Mundaring, Australia, has made significant contributions to the fields of wound treatment and neuroprotection. With a total of two patents to his name, his work focuses on cutting-edge technologies aimed at advancing healthcare solutions.

Latest Patents

Mark's latest patents reflect his ingenuity in addressing critical medical challenges. The first patent titled "Compositions and uses thereof for the treatment of wounds" presents a topical composition designed to reduce, delay, or prevent apoptosis and necrosis induced by dermal wounding. This innovation comprises an AP-1 signaling inhibitor that enhances cell proliferation and a suitable carrier for dermal application. The invention also details a method of treating dermal wounds by applying this composition to affected subjects.

The second patent, "Neuroprotective peptide inhibitors of AP-1 signaling and uses therefor," focuses on AP-1 signaling inhibitory peptides. This invention provides specific peptide sequences that offer potential treatment methods for neurological disorders. By administering these peptides or their compositions, Mark's work opens new avenues in neuroprotection.

Career Highlights

Throughout his career, Mark Fear has collaborated with notable organizations such as Phylogica Limited and The McComb Foundation, Inc. His experience in these companies has facilitated the advancement of his research and patented innovations. Mark’s dedication is evident in his pursuit of effective solutions for both dermal and neurological health.

Collaborations

Mark has worked alongside accomplished professionals, including Paul Michael Watt and Nadia Milech. These collaborative efforts have not only enriched his research endeavors but have also contributed to the broader scientific community's understanding of AP-1 signaling and its implications in medical treatments.

Conclusion

In conclusion, Mark Fear stands out as a talented inventor whose work in wound treatment and neuroprotection is paving the way for future innovations. His patents demonstrate a deep commitment to improving health outcomes, showcasing the positive impact that dedicated inventors can have on society. As he continues to explore new horizons in medical research, Mark Fear's contributions will undoubtedly inspire and lead to further advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…